Easterly Investment Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-486,623
Closed -$7.25M 202
2025
Q1
$7.25M Buy
486,623
+88,989
+22% +$1.37M 0.6% 61
2024
Q4
$5.93M Buy
+397,634
New +$6.48M 0.47% 74
2024
Q1
Sell
-271,973
Closed -$3.92M 227
2023
Q4
$3.92M Buy
+271,973
New +$3.7M 0.42% 72
2021
Q4
Sell
-7,415
Closed -$243K 215
2021
Q3
$243K Sell
7,415
-537
-7% -$17.2K 0.02% 190
2021
Q2
$241K Buy
+7,952
New +$262K 0.03% 100

Other funds holding OGN

Easterly Investment Partners's OGN Position: Q2 2025 in Review

Easterly Investment Partners sold out of Organon & Co (OGN) in Q2 2025, closing a stake of 486,623 shares — an estimated $7.25M sold.

Easterly Investment Partners first reported a position in OGN in Q2 2021 and held it in 5 quarters. The position peaked at $7.25M in Q1 2025. 695 funds tracked by Wall St. Rank hold OGN as of Q2 2025.

  • Easterly Investment Partners reported no remaining Organon & Co position as of Q2 2025 after selling out during the quarter.
  • Easterly Investment Partners sold 486,623 Organon & Co shares in Q2 2025, an estimated $7.25M.
  • Easterly Investment Partners first reported a position in Organon & Co in Q2 2021 and held it in 5 quarters.
  • Easterly Investment Partners's Organon & Co position peaked at $7.25M in Q1 2025.
  • 695 funds tracked by Wall St. Rank held Organon & Co as of Q2 2025.

Based on Easterly Investment Partners's 13F filing for Q2 2025, filed 29 Jul 2025.